Idiopathic detrusor sphincter dyssynergia in neurologically normal patients with voiding abnormalities.
Jørgensen TM, Djurhuus JC, Schrøder HD.
Eur Urol. 1982;8(2):107-10. doi: 10.1159/000473490.
Idiopathic detrusor-urethral dyssynergia in dogs: a retrospective analysis of 22 cases.
Díaz Espiñeira MM, Viehoff FW, Nickel RF.
J Small Anim Pract. 1998 Jun;39(6):264-70. doi: 10.1111/j.1748-5827.1998.tb03648.x.
[THE USE OF BOTULINUM TOXIN IN UROLOGY].
Anis O, Kitrey ND.
Harefuah. 2021 Sep;160(9):615-618.
Chinese botulinum toxin A for the treatment of lower urinary tract dysfunction: It works just as well.
Zhang F, Liu Q, Liao L, Li X, Zhang X.
Bladder (San Franc). 2022 Sep 14;9(1):e47. doi: 10.14440/bladder.2022.847. eCollection 2022.
Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction.
Kuo HC.
Ci Ji Yi Xue Za Zhi. 2016 Jul-Sep;28(3):89-93. doi: 10.1016/j.tcmj.2016.07.001. Epub 2016 Aug 28.
Applications of Botulinum toxin in urogynaecology.
Sinha D, Karri K, Arunkalaivanan AS.
Eur J Obstet Gynecol Reprod Biol. 2007 Jul;133(1):4-11. doi: 10.1016/j.ejogrb.2006.12.014. Epub 2007 Feb 2.
Current and potential urological applications of botulinum toxin A.
Jiang YH, Liao CH, Kuo HC.
Nat Rev Urol. 2015 Sep;12(9):519-33. doi: 10.1038/nrurol.2015.193. Epub 2015 Aug 11.
Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
Leippold T, Reitz A, Schurch B.
Eur Urol. 2003 Aug;44(2):165-74. doi: 10.1016/s0302-2838(03)00250-1.
Botulinum toxin for conditions of the female pelvis.
El-Khawand D, Wehbe S, Whitmore K.
Int Urogynecol J. 2013 Jul;24(7):1073-81. doi: 10.1007/s00192-012-2035-1. Epub 2013 Jan 24.
Botulinum toxin injection for lower urinary tract dysfunction.
Kuo YC, Kuo HC.
Int J Urol. 2013 Jan;20(1):40-55. doi: 10.1111/j.1442-2042.2012.03035.x. Epub 2012 May 9.
